免疫健康サプリメントの市場規模、シェア、動向分析レポート：製品別、剤形別、供給源タイプ別、投薬形態別、流通チャネル別、地域別、セグメント別予測、2024年～2030年

免疫健康サプリメント市場の成長と動向：

免疫健康サプリメントの世界市場規模は2030年に528億1,000万米ドルと推定され、2024～2030年にかけてCAGR 10.72%で成長すると予測されます。

細菌、真菌、ウイルス、寄生虫など複数の微生物によって引き起こされる様々な感染症の蔓延が拡大していることと、身体の免疫システムを高めるサプリメントに対する需要が高まっていることが相まって、免疫健康サプリメントの採用が世界中で増加すると予想されています。その上、COVID-19の大流行による免疫力向上製品の採用増加も、予測数年間の市場成長を加速させると予測されています。Council for Responsible Nutrition（CRN）の2020年のレポートによると、米国人の栄養補助食品の消費量は約73％でした。しかし、免疫の健康のために栄養補助食品を摂取する割合は、2019～2020年にかけて27%から32%に増加しています。

2020年現在、ビタミンミネラルサプリメント部門が最大の売上シェアを占めています。ビタミンC、D、マルチビタミン、ミネラルの採用が増加した結果、同市場における同セグメントの収益シェアが高くなりました。不健康な食事、限られた身体活動、座りがちなライフスタイルは、特に北米や欧州などの先進地域において、個人の免疫力を向上させるためにビタミンとミネラルの摂取量を増加させる主要要因となっています。しかし、患者人口の増加とビタミン・ミネラル摂取に対する意識の高まりは、予測期間中にアジア太平洋やラテンアメリカなどの新興経済圏の市場成長を促進すると予想される主要要因です。しかし、ハーブサプリメントセグメントは、副作用のない免疫力ブースターとして長期的な消費に人気があるため、第2位の製品セグメントであるとも予想されています。

形態別では、錠剤セグメントが2020年に最大の収益シェアを占めました。賞味期限が長く、個人の嗜好性が高いことから、錠剤セグメントが主流になると予想されます。錠剤はカプセルよりも安定性が高く、特に湿った環境では安定性が高いです。さらに、錠剤は他の形態のサプリメントよりも主要な市場参入企業によって主に製造されています。さらに、錠剤は耐久性があり、安価で、2つに分割でき、高用量に対応できるなどの特性があり、市場での高い採用率と最大の価値シェアが予想されます。

呼吸器感染症セグメントは2020年に最大の収益シェアを占めました。COPD、喘息、COVID19などの呼吸器疾患の有病率の増加により、免疫健康サプリメントの採用はここ数年で増加しています。特に、昨年からの生命を脅かすコロナウイルス疾患の急増により、呼吸器感染症を管理するための免疫強化製品の採用が増加しています。ビタミンC、D、亜鉛などのミネラル、プロバイオティクスなどのサプリメントを摂取することで、呼吸器感染症のリスク、感染期間、重症度を軽減するユニークな特性があります。

2020年現在、セルフメディケーション部門は処方箋別の部門よりも最大の収益シェアを占めています。これは、世界中の人々がセルフメディケーションのサプリメントを使用する割合が高いためと考えられます。さらに、ビタミンとミネラルのサプリメントのほとんどは処方箋を必要としないです。薬局や食料品店、コンビニエンスストアで購入することができます。また、COVID19の影響で免疫力向上製品を使用する意識が個人の間で高まっていることも、セルフメディケーションセグメントに高い市場シェアをもたらすと予測されています。

薬局/ドラッグストアセグメントが市場を独占し、2020年に最大の収益を占める。多種多様な製品が入手可能であることと、消費者が薬局で免疫健康サプリメントを購入することを好む傾向が高いことが、このセグメントで最大の市場シェアを占めている要因です。さらに、消費者が処方箋別の製品と市販製品の両方を利用できることも、予測期間中に薬局/ドラッグストア部門の成長を加速させると予想されます。

北米が市場を独占し、2020年に最大の収益シェアを占めました。さまざまな健康障害の有病率の増加、免疫強化製品の使用量の増加、消費者の高い支出能力が、この地域の市場シェアの大半を占めると予想される要因です。しかし、中国、インド、日本などのアジア太平洋諸国は、人口が多く、認知度が向上し、消費者基盤が拡大しているため、予測期間中に大きな成長が見られると予想されます。

免疫健康サプリメント市場レポートハイライト

• 複数の感染症が流行し、免疫力向上への意識が高まっていることから、市場は予測期間中に高成長が見込まれます。
• 2020年には、免疫健康に対する高い需要と用途の増加により、ビタミン・ミネラルサプリメントセグメントが市場を席巻します。
• 呼吸器感染症用途は、世界中で呼吸器感染症のリスクを軽減するために免疫サプリメントの採用が増加していることから、2020年の市場を独占しました。
• セルフメディケーション市場は、処方箋別のよりもセルフメディケーションでサプリメントを使用することへの嗜好の高まりにより、2020年の市場を独占しました。
• 薬局/ドラッグストア市場は、幅広い製品が入手可能で消費者の嗜好が高いことから、2020年の市場を独占しました。
• 北米は、消費能力が高く、免疫健康食品の利用が増加していることから、2020年の市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 免疫健康サプリメント市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 免疫健康サプリメント市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 免疫健康サプリメント市場：製品、推定・動向分析

• 製品セグメントダッシュボード
• 世界の免疫健康サプリメント市場の製品変動分析
• 世界の免疫健康サプリメント市場規模と動向分析、製品別、2018～2030年
• ビタミンミネラルサプリメント
• アミノ酸
• オメガ3脂肪酸
• ハーブサプリメント
• プロバイオティクスサプリメント
• その他

第5章 免疫健康サプリメント市場：剤形、推定・動向分析

• 剤形セグメントダッシュボード
• 世界の免疫健康サプリメント市場の剤形変動分析
• 世界の免疫健康サプリメント市場規模と動向分析、剤形別、2018～2030年
• カプセル
• 錠剤
• 粉末
• 液体
• ソフトジェル
• その他

第6章 免疫健康サプリメント市場：供給源タイプ、推定・動向分析

• 供給源タイプセグメントダッシュボード
• 世界の免疫健康サプリメント市場の供給源タイプ変動分析
• 世界の免疫健康サプリメント市場規模と動向分析、供給源タイプ別、2018～2030年
• 天然
• 合成

第7章 免疫健康サプリメント市場：投薬形態、推定・動向分析

• 投薬形態セグメントダッシュボード
• 世界の免疫健康サプリメント市場の投薬形態変動分析
• 世界の免疫健康サプリメント市場規模と動向分析、投薬形態別、2018～2030年
• 処方箋
• セルフメディケーション

第8章 免疫健康サプリメント市場：流通チャネル、推定・動向分析

• 流通チャネルセグメントダッシュボード
• 世界の免疫健康サプリメント市場の流通チャネル変動分析
• 世界の免疫健康サプリメント市場規模と動向分析、流通チャネル別、2018～2030年
• オフライン
• オンライン

第9章 免疫健康サプリメント市場：製品、剤形、供給源タイプ、投薬形態、流通チャネル別の地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Nature's Way
  • NOW Foods
  • Garden of Life
  • Thorne Research
  • Nordic Naturals
  • Solaray
  • Pure Encapsulations
  • The Nature's Bounty Co.
  • MegaFood
  • Jarrow Formulas
  • Life Extension
  • Metagenics
  • Xymogen
  • Designs for Health
  • Douglas Laboratories
  • Bayer AG
  • Standard Process
  • Klaire Labs
  • Integrative Therapeutics
  • Amway, Co.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global immune health supplements market, by region, 2018 - 2030 (USD Million)
• Table 3 Global immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 4 Global immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 5 Global immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 6 Global immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 7 Global immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 8 North America immune health supplements market, by country, 2018 - 2030 (USD Million)
• Table 9 North America immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 10 North America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 11 North America immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 12 North America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 13 North America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14 U.S. immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 15 U.S. immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 16 U.S. immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 17 U.S. immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 18 U.S. immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 Canada immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 20 Canada immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 21 Canada immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 22 Canada immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 23 Canada immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 24 Mexico immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 25 Mexico immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 26 Mexico immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 27 Mexico immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 28 Mexico immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 29 Europe immune health supplements market, by country, 2018 - 2030 (USD Million)
• Table 30 Europe immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 31 Europe immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 32 Europe immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 33 Europe immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 34 Europe immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 35 Germany immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 36 Germany immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 37 Germany immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 38 Germany immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 39 Germany immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40 UK immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 41 UK immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 42 UK immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 43 UK immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 44 UK immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 45 France immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 46 France immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 47 France immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 48 France immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 49 France immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 Italy immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 51 Italy immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 52 Italy immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 53 Italy immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 54 Italy immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 Spain immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 56 Spain immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 57 Spain immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 58 Spain immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 59 Spain immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60 Denmark immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 61 Denmark immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 62 Denmark immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 63 Denmark immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 64 Denmark immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 65 Sweden immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 66 Sweden immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 67 Sweden immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 68 Sweden immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 69 Sweden immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 70 Norway immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 71 Norway immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 72 Norway immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 73 Norway immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 74 Norway immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific immune health supplements market, by country, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 81 China immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 82 China immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 83 China immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 84 China immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 85 China immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 86 Japan immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 87 Japan immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 88 Japan immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 89 Japan immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 90 Japan immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 91 India immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 92 India immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 93 India immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 94 India immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 95 India immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 96 South Korea immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 97 South Korea immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 98 South Korea immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 99 South Korea immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 100 South Korea immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 101 Australia immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 102 Australia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 103 Australia immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 104 Australia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 105 Australia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 106 Thailand immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 107 Thailand immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 108 Thailand immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 109 Thailand immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 110 Thailand immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 111 Latin America immune health supplements market, by country, 2018 - 2030 (USD Million)
• Table 112 Latin America immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 113 Latin America immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 114 Latin America immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 115 Latin America immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 116 Latin America immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 117 Brazil immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 118 Brazil immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 119 Brazil immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 120 Brazil immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 121 Brazil immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 122 Argentina immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 123 Argentina immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 124 Argentina immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 125 Argentina immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 126 Argentina immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 127 MEA immune health supplements market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 129 MEA immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 130 MEA immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 131 MEA immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 132 MEA immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 133 South Africa immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 134 South Africa immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 135 South Africa immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 136 South Africa immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 137 South Africa immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 143 UAE immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 144 UAE immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 145 UAE immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 146 UAE immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 147 UAE immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)
• Table 148 Kuwait immune health supplements market, by product, 2018 - 2030 (USD Million)
• Table 149 Kuwait immune health supplements market, by formulation, 2018 - 2030 (USD Million)
• Table 150 Kuwait immune health supplements market, by source type, 2018 - 2030 (USD Million)
• Table 151 Kuwait immune health supplements market, by mode of medication, 2018 - 2030 (USD Million)
• Table 152 Kuwait immune health supplements market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Immune health supplements market: Market outlook
• Fig. 5 Immune health supplements market: Segment outlook
• Fig. 6 Immune health supplements market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Immune health supplements market driver impact
• Fig. 9 Immune health supplements market restraint impact
• Fig. 10 Immune health supplements market: Product outlook and key takeaways
• Fig. 11 Immune health supplements market: Product movement analysis
• Fig. 12 Vitamin & mineral supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Vitamin C supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Vitamin D supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Vitamin B complex supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Multivitamins market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Selenium supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Zinc supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Amino acids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Omega-3 fatty acids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Herbal supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Probiotics supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Immune health supplements market: Formulation outlook and key takeaways
• Fig. 26 Immune health supplements market: Formulation movement analysis
• Fig. 27 Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Powder market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Liquid market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Softgels application market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 32 Others market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 33 Immune health supplements market: Source type outlook and key takeaways
• Fig. 34 Immune health supplements market: Source type movement analysis
• Fig. 35 Natural market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Synthetic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Immune health supplements market: Mode of medication outlook and key takeaways
• Fig. 38 Immune health supplements market: Mode of medication movement analysis
• Fig. 39 Prescription-based market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Self-medication market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Immune health supplements market: Distribution channel outlook and key takeaways
• Fig. 42 Immune health supplements market: Distribution channel movement analysis
• Fig. 43 Offline market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Pharmacies & drug stores market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Hypermarkets/supermarkets market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Online market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Global immune health supplements market: Regional outlook and key takeaways
• Fig. 49 Global immune health supplements market: Regional movement analysis
• Fig. 50 North America immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 U.S. immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Canada immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Mexico immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Europe immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 UK immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Germany immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 France immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Italy immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Spain immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Denmark immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Sweden immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Norway immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Asia Pacific immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 China immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Japan immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 India immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Thailand immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 South Korea immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Australia immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Latin America immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Brazil immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Argentina immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Middle East and Africa immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Africa immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Saudi Arabia immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 UAE immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Kuwait immune health supplements market estimates and forecasts, 2018 - 2030 (USD Million)

Immune Health Supplements Market Growth & Trends:

The global immune health supplements market size was estimated at USD 52.81 billion in 2030 and is projected to grow at a CAGR of 10.72% from 2024 to 2030. The growing prevalence of various infectious diseases caused by several micro-organisms, such as bacteria, fungi, viruses, and parasites, coupled with the rising demand for supplements to increase the body's immune system, is expected to boost the immune health supplements adoption across the globe. Besides, increasing adoption of immunity-boosting products due to the COVID-19 pandemic is also anticipated to accelerate the market growth over the forecast years. According to the Council for Responsible Nutrition (CRN) report in 2020, the consumption of dietary supplements among Americans was about 73 percent. However, taking dietary supplements among individuals for immune health has been increased from 27 percent to 32 percent from 2019 to 2020.

As of 2020, the vitamin and mineral supplements segment held the largest revenue share. The increasing adoption of vitamin C, D, multivitamins, and minerals resulted in a high revenue share for the segment in the market. An unhealthy diet limited physical activity, and a sedentary lifestyle are the key factors responsible for increasing vitamin and mineral intake to improve an individual's immunity, especially in the developed regions such as North America and Europe. However, the increasing patient population and growing awareness for vitamin and mineral consumption are the major factors expected to boost market growth in emerging economies such as Asia Pacific and Latin America during the forecast period. However, the herbal supplements segment is also anticipated to be the second-largest product segment due to its popularity for long-term consumption as immunity boosters without any side effects.

By form, the tablets segment accounted for the largest revenue share in 2020. Due to its longer shelf life and high preference of adoption among the individual's tablets segment is expected to be the dominated segment. Tablets are more stable than the capsule, particularly in moist environments. In addition, tablets are largely manufactured by the key market players than the other form of supplements. Further, properties of tablets such as durability, inexpensive, can be split into two parts, and higher dosage accommodation is anticipated its high adoption and maximum value share in the market.

The respiratory tract infection segment held the largest revenue share in 2020. Due to the increasing prevalence of respiratory disorders such as COPD, asthma, COVID19, immune health supplements adoption has increased in the last couple of years. Particularly, the rapid rise in life-threatening coronavirus disease from the last year has increased the adoption of immunity-boosting products to manage respiratory tract infections. Taking supplements such as Vitamin C, D, and minerals such as zinc and probiotics offers unique properties to reduce the risk of respiratory tract infection, duration, and severity of infection.

As of 2020, the self-medication segment accounted for the largest revenue share than the prescription-based segment. It can be attributed due to the high percentage of self-medicated supplements using the population around the globe. Further, most of the vitamins and mineral supplements do not require a prescription. One can purchase them from pharmacies, groceries, and any convenience stores. Besides, the growing awareness among the individuals to use immunity-boosting products due to COVID19 is also expected to provide a high market share to the self-medication segment over the forecast years globally.

The pharmacies/drug stores segment dominated the market and accounted for the largest revenue in 2020. The availability of a wide variety of products and the high preference of consumers to buy immune health supplements from pharmacies are the factors responsible for the largest market share of this segment. Moreover, the availability of both prescriptions based and over-the-counter products for the consumers is also expected to accelerate the growth of the Pharmacies/drug stores segment over the forecast years.

North America dominated the market and accounted for the largest revenue share in 2020. The increasing prevalence of various health disorders, increasing usage of immune-enhancing products, and high spending capacity by the consumers are the factors anticipated to provide the majority of market share to the region. However, Asia Pacific countries, such as China, India, and Japan, are expected to witness significant growth over the forecast years due to the large population, increasing awareness, and growing consumer base in these countries.

Immune Health Supplements Market Report Highlights:

• The market is expected to grow well over the forecast period owing to the increasing prevalence of several infectious diseases and growing awareness to improve immune health
• The vitamin and mineral supplements segment dominated the market in 2020 owing to high demand and increasing use for immune health
• The respiratory tract infection application segment dominated the market in 2020 owing to the increasing adoption of immune supplements to reduce the risk of respiratory tract infection across the globe
• The self-medication segment dominated the market in 2020 majorly due to a growing preference for self-medicated use of supplements than prescription-based
• The pharmacies/drug stores segment dominated the market in 2020 owing to the availability of a wide range of products and high consumer preference
• North America dominated the market in 2020 majorly due to high spending capacity and increasing uses of immune health supplements in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Formulation Segment
  • 1.2.3. Source Type Segment
  • 1.2.4. Mode of Medication Segment
  • 1.2.5. Distribution Channel Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Immune Health Supplements Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing health consciousness
    • 3.2.1.2. Rising prevalence of chronic diseases
    • 3.2.1.3. Growing geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations
• 3.3. Immune Health Supplements Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Immune Health Supplements Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Immune Health Supplements Market Product Movement Analysis
• 4.3. Global Immune Health Supplements Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Vitamin & Mineral Supplements
  • 4.4.1. Vitamin & mineral supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Vitamin C Supplements
    • 4.4.2.1. Vitamin C supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Vitamin D Supplements
    • 4.4.3.1. Vitamin D supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Vitamin B Complex Supplements
    • 4.4.4.1. Vitamin B complex supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Multivitamins
    • 4.4.5.1. Multivitamins market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Selenium Supplements
    • 4.4.6.1. Selenium supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Zinc Supplements
    • 4.4.7.1. Zinc supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.8. Others
    • 4.4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Amino Acids
  • 4.5.1. Amino acids market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Omega-3 Fatty Acids
  • 4.6.1. Omega-3 fatty acids market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Herbal Supplements
  • 4.7.1. Herbal supplements market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Probiotic Supplements
  • 4.8.1. Probiotic supplements market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immune Health Supplements Market: Formulation Estimates & Trend Analysis

• 5.1. Formulation Segment Dashboard
• 5.2. Global Immune Health Supplements Market Formulation Movement Analysis
• 5.3. Global Immune Health Supplements Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
• 5.4. Capsules
  • 5.4.1. Capsules market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Tablets
  • 5.5.1. Tablets market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Powder
  • 5.6.1. Powder market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Liquid
  • 5.7.1. Liquid market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Softgels
  • 5.8.1. Softgels market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immune Health Supplements Market: Source Type Estimates & Trend Analysis

• 6.1. Source Type Segment Dashboard
• 6.2. Global Immune Health Supplements Market Source Type Movement Analysis
• 6.3. Global Immune Health Supplements Market Size & Trend Analysis, by Source Type, 2018 to 2030 (USD Million)
• 6.4. Natural
  • 6.4.1. Natural market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Synthetic
  • 6.5.1. Synthetic market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immune Health Supplements Market: Mode of Medication Estimates & Trend Analysis

• 7.1. Mode of Medication Segment Dashboard
• 7.2. Global Immune Health Supplements Market Mode of Medication Movement Analysis
• 7.3. Global Immune Health Supplements Market Size & Trend Analysis, by Mode of Medication, 2018 to 2030 (USD Million)
• 7.4. Prescription-based
  • 7.4.1. Prescription-based market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Self-medication
  • 7.5.1. Self-medication market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Immune Health Supplements Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Distribution Channel Segment Dashboard
• 8.2. Global Immune Health Supplements Market Distribution Channel Movement Analysis
• 8.3. Global Immune Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 8.4. Offline
  • 8.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Pharmacies & Drug Stores
    • 8.4.2.1. Pharmacies & drug stores market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Hypermarkets/Supermarkets
    • 8.4.3.1. Hypermarkets/supermarkets market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Others
    • 8.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Online
  • 8.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Immune Health Supplements Market: Regional Estimates & Trend Analysis by Product, Formulation, Source Type, Mode of Medication, and Distribution Channel

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Regulatory framework
    • 9.5.8.3. Competitive scenario
    • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Regulatory framework
    • 9.5.9.3. Competitive scenario
    • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. MEA
  • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Regulatory framework
    • 9.8.4.3. Competitive scenario
    • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Regulatory framework
    • 9.8.5.3. Competitive scenario
    • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. Company Profiles/Listing
  • 10.4.1. Nature's Way
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. NOW Foods
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Garden of Life
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Thorne Research
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Nordic Naturals
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Solaray
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Pure Encapsulations
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. The Nature's Bounty Co.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. MegaFood
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Jarrow Formulas
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives
  • 10.4.11. Life Extension
    • 10.4.11.1. Company overview
    • 10.4.11.2. Financial performance
    • 10.4.11.3. Product benchmarking
    • 10.4.11.4. Strategic initiatives
  • 10.4.12. Metagenics
    • 10.4.12.1. Company overview
    • 10.4.12.2. Financial performance
    • 10.4.12.3. Product benchmarking
    • 10.4.12.4. Strategic initiatives
  • 10.4.13. Xymogen
    • 10.4.13.1. Company overview
    • 10.4.13.2. Financial performance
    • 10.4.13.3. Product benchmarking
    • 10.4.13.4. Strategic initiatives
  • 10.4.14. Designs for Health
    • 10.4.14.1. Company overview
    • 10.4.14.2. Financial performance
    • 10.4.14.3. Product benchmarking
    • 10.4.14.4. Strategic initiatives
  • 10.4.15. Douglas Laboratories
    • 10.4.15.1. Company overview
    • 10.4.15.2. Financial performance
    • 10.4.15.3. Product benchmarking
    • 10.4.15.4. Strategic initiatives
  • 10.4.16. Bayer AG
    • 10.4.16.1. Company overview
    • 10.4.16.2. Financial performance
    • 10.4.16.3. Product benchmarking
    • 10.4.16.4. Strategic initiatives
  • 10.4.17. Standard Process
    • 10.4.17.1. Company overview
    • 10.4.17.2. Financial performance
    • 10.4.17.3. Product benchmarking
    • 10.4.17.4. Strategic initiatives
  • 10.4.18. Klaire Labs
    • 10.4.18.1. Company overview
    • 10.4.18.2. Financial performance
    • 10.4.18.3. Product benchmarking
    • 10.4.18.4. Strategic initiatives
  • 10.4.19. Integrative Therapeutics
    • 10.4.19.1. Company overview
    • 10.4.19.2. Financial performance
    • 10.4.19.3. Product benchmarking
    • 10.4.19.4. Strategic initiatives
  • 10.4.20. Amway, Co.
    • 10.4.20.1. Company overview
    • 10.4.20.2. Financial performance
    • 10.4.20.3. Product benchmarking
    • 10.4.20.4. Strategic initiatives